nuvicare hives relief

Generic: fexofenadine hydrochloride

Labeler: nuvicare llc
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nuvicare hives relief
Generic Name fexofenadine hydrochloride
Labeler nuvicare llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

fexofenadine hydrochloride 180 mg/1

Manufacturer
NUVICARE LLC

Identifiers & Regulatory

Product NDC 84324-031
Product ID 84324-031_8a758eab-e855-4cac-85e1-c7df0aa2150d
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA210137
Listing Expiration 2027-12-31
Marketing Start 2026-01-21

Pharmacologic Class

Classes
histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 84324031
Hyphenated Format 84324-031

Supplemental Identifiers

RxCUI
997420
UNII
2S068B75ZU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nuvicare hives relief (source: ndc)
Generic Name fexofenadine hydrochloride (source: ndc)
Application Number ANDA210137 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (84324-031-01)
source: ndc

Packages (1)

Ingredients (1)

fexofenadine hydrochloride (180 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8a758eab-e855-4cac-85e1-c7df0aa2150d", "openfda": {"unii": ["2S068B75ZU"], "rxcui": ["997420"], "spl_set_id": ["a8e11094-ca69-488d-a720-b8129f17f505"], "manufacturer_name": ["NUVICARE LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (84324-031-01)", "package_ndc": "84324-031-01", "marketing_start_date": "20260121"}], "brand_name": "Nuvicare Hives Relief", "product_id": "84324-031_8a758eab-e855-4cac-85e1-c7df0aa2150d", "dosage_form": "TABLET", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "84324-031", "generic_name": "FEXOFENADINE HYDROCHLORIDE", "labeler_name": "NUVICARE LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Nuvicare Hives Relief", "active_ingredients": [{"name": "FEXOFENADINE HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA210137", "marketing_category": "ANDA", "marketing_start_date": "20260121", "listing_expiration_date": "20271231"}